Asymmetric Unit (4, 4)
No. | Name | Evidence | Residues | Description |
1 | AC1 | SOFTWARE | GLU A:26 , GLU A:28 , ARG A:41 , ARG A:43 , THR A:45 | binding site for residue TOE A 301 |
2 | AC2 | SOFTWARE | GLY A:229 , ASN A:231 , ARG B:9 , LYS B:11 , PHE B:13 , ASP B:110 | binding site for residue TOE B 301 |
3 | AC3 | SOFTWARE | MET B:14 , GLN B:38 , GLU B:40 , ILE B:42 , LEU B:57 , SER B:58 , PRO B:59 , HIS B:60 , SER B:65 , VAL B:66 , TRP B:89 , ARG B:91 , TYR B:116 , GLU B:144 , SER B:157 , LEU B:173 , TYR B:177 , GLN B:212 , TYR B:213 , GLU B:214 , HOH B:406 , HOH B:421 | binding site for Di-peptide PHE B 61 and CRQ B 62 |
4 | AC4 | SOFTWARE | GLN B:38 , GLU B:40 , SER B:58 , PRO B:59 , HIS B:60 , PHE B:61 , VAL B:66 , ALA B:67 , ILE B:68 , TRP B:89 , ARG B:91 , TYR B:116 , GLU B:144 , SER B:157 , LEU B:173 , TYR B:177 , GLN B:212 , TYR B:213 , GLU B:214 , HOH B:406 , HOH B:409 , HOH B:421 | binding site for Di-peptide CRQ B 62 and SER B 65 |
|